Recombinant human luteinizing hormone: A partial physicochemical, biological and immunological characterization

Molecular Human Reproduction

Volumn 2, Issue 10, 1996, Pages 799-806

  Talbot, James A ^a   Mitchell, Robert ^a   Hoy, Aileen M ^a   Lambert, Ann ^a   Gauher, Anjali ^a   Hilton, Barry ^a   McLoughlin, Julie D ^a   Robertson, William R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chromatofocusing; Lectin chromatography; rLH heterogeneity

Indexed keywords

CONCANAVALIN A; HYBRID PROTEIN; LUTEINIZING HORMONE;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; CHEMISTRY; CHO CELL; DRUG EFFECT; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; ISOELECTRIC FOCUSING; ISOLATION AND PURIFICATION; LEYDIG CELL; MALE; MOLECULAR CLONING; MOUSE; PH; RADIOIMMUNOASSAY;

ANIMALS; CHO CELLS; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; CONCANAVALIN A; CRICETINAE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOELECTRIC FOCUSING; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; MICE; RADIOIMMUNOASSAY; RECOMBINANT FUSION PROTEINS;

EID: 0030252736     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/2.10.799     Document Type: Article

References (49)

1. Baird, D.T. (1996) Recent developments in gonadotrophins for clinical therapy. J. Endocrinol., 148, S38.
2. Chandrasekher, Y.A., Hutchison, J.S., Zelinski-Wooten, M.B. et al. (1994) Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing-hormone to mimic the midcycle gonadotropin surge. J. Clin. Endocrinol. Metab., 79, 298-306.
3. Chappel, S.C. (1990) Biological to immunological ratios: re-evaluation of a concept. (Editorial.) J. Clin. Endocrinol. Metab., 70, 1494-1495.
4. Chappel, S.C. and Howles, C. (1991) Re-evaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
5. Creus, S., Pellizzari, E., Cigorraga, S.B. and Campo, S. (1996) FSH isoforms: bio and immuno-activities in post-menopausal and normal menstruating women. Clin. Endocrinol., 44, 181-189.
6. Ding, Y. and Huhtaniemi, I. (1991) Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immuno ratio of LH in healthy women and in women with polycystic ovarian disease. Hum. Reprod., 6, 346-350.
7. Emperaire, J.-C. and Ruffie, A. (1991) Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome. Hum. Reprod., 6, 506-510.
8. Grabinski, M., Mitchell, R., Bauerfield, C. and Robertson, W.R. (1992) Reproducibility of chromatofocussed LH and FSH on untreated and hydoxyapatite treated plasma from post menopausal women. [Abstr.] J. Endocrinol., 132, 185.
9. Green, E.D. and Baenziger, J.U. (1988) Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. I. Structural elucidation of sulphated and sialylated oligosaccharides on pituitary glycoprotein hormones: implication of biologic function. J. Biol. Chem., 263, 36-44.
10. Haavisto, A., Sinberg, N. and Huhtaniemi, I. (1990) The bio/immuno ratio of serum luteinizing hormone increases after orchidectomy in prostatic cancer patients and is associated with decreased molecular weight and appearance of isohormones with alkaline pI values. Biol. Reprod., 42, 597-602.
11. Harlin, J., Khan, S.A. and Diczfalusy, E. (1986) Molecular composition of luteinizing hormone and follicle-stimulating hormone in commercial gonadotropin preparations. Fertil. Steril., 46, 1055-1059.
12. Harris S.D., Lambert, A., Anobile, C.J. et al. (1996) Concanavalin-A (Con-A) affinity chromatography of recombinant human follicle stimulating hormone (rhFSH; Puregon; Organon-32489). Comparison with Metrodin, Metrodin-HP and IS 70/45. [Abstr.] Hum. Reprod., 11 (Abstr. book) 1 O23.
13. Hillier, S.G. (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod., 9, 188-191.
14. Hull, M., Corrigan, E., Piazzi, A. and Loumaye, E. (1994) Recombinant human luteinising hormone: an effective new gonadotropin preparation [Letter]. Lancet, 344, 334-335.
15. Jeffcoate, S.L. (1993) Analytical and clinical significance of peptide hormone heterogeneity with particular regard to growth hormone and luteinising hormone in plasma. Clin. Endocrinol., 38, 113-121.
16. Lambert, A., Rodgers, M., Mitchell, R. et al. (1995) In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Mol. Hum. Reprod., 1,
17. see Hum. Reprod., 10, 1928-1935.
18. Matikainen, T., De Leeuw, R., Mannaerts, B. and Huhtaniemi, I. (1994) Circulating bioactive and immunoreactive recombinant human follicle-stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil. Steril., 61, 62-69.
19. Medri, G., Sergi, I., Papandreou, M.-J. et al. (1994) Dual activity of human pituitary thyrotrophin isoforms on thyroid cell growth. J. Mol. Endocrinol., 13, 187-198.
20. Mitchell, R., Bauerfield, C., Schaefer, F. et al. (1994) Less acidic forms of LH are associated with lower testosterone secretion in normal men and men with chronic renal failure. Clin. Endocrinol., 41, 65-73.
21. Out, H.L., Mannaerts, B.M.J.L., Coelingh-Bennink, H.J.T. et al. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
22. Padmanabhan, V., Lang, L.L., Sonstein, J. et al. (1988) Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J. Clin. Endocrinol. Metab., 67, 465-473.
23. Papandreou, M., Asteria, C., Pettersson, K. et al. (1993) Concanavalin A affinity chromatography of human gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions. J. Clin. Endocrinol. Metab., 76, 1008-1013.
24. Pickles, A.J., Peers, N., Robertson, W.R. and Lambert, A. (1992) Different isoforms of human pituitary TSH have different relative biological activities. J. Mol. Endocrinol., 9, 251-256.
25. Porchet, H.C., Le Cotonnec, J.-Y., Neuteboom, S. et al. (1995) Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J. Clin. Endocrinol. Metab., 80, 667-673.
26. Reader, S.C., Robertson, W.R. and Diczfalusy, E. (1983) Microheterogeneity of luteinizing hormone in pituitary glands from women of pre- and postmenopausal age. Clin. Endocrinol. (Oxf). 19, 355-363.
27. Recombinant human FSH study group (1995) Clinical assessment of recombinant follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
28. Regan, L., Owen, E.J. and Jacobs, H.S. (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet, 336, 1141-1144.
29. Robertson, W.R. and Mitchell, R. (1995) Bioassays and immunoassays: resolving the differences. Proc. U.K. NEQAS Meeting, 1, 1-11.
30. Robertson, W.R. and Bidey, S.P. (1990) The in vitro bioassay of peptide hormones. In Siddle, K. and Hutton, H. (eds), Peptide Hormone Secretion: a Practical Approach. Oxford University Press, Oxford, pp. 150-154.
31. Rodgers, M., Lambert, A., McLoughlin, J.D. et al. (1995) Variability in the immunoreactive and bioactive FSH content of human urinary menopausal gonadotrophin preparations. Hum. Reprod., 10, 1982-1986.
32. Rodgers, M., Mitchell, R., Lambert, A. et al. (1992) Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clin. Endocrinol., 37, 558-564.
33. Rose, M.P. and Gaines, R.E. (1996) First International Standard for recombinant DNA-derived human follicle stimulating hormone: calibration by in vitro bioassay and characterisation by immunoassay and in vitro bioassay. J. Endocrinol., 148, 309.
34. Simon, J.A., Danforth, D.R., Hutchinson, J.S. and Hodgen, G.D. (1988) Characterization of recombinant DNA derived human luteinizing hormone in vitro and in vivo. Efficacy in ovulation induction and corpus Iuteum support. J. Am. Med. Assoc., 259, 3290-3295.
35. Snyder, P.J., Bashey, H.M., Montecinos, A. et al. (1989) Secretion of multiple forms of human luteinizing hormone by cultured fetal human pituitary cells. J. Clin. Endocrinol. Metab., 68, 1033-1038.
36. Snyder, P.J., Bashey, H.M., Gatewood, C.V. and Karowe, M. (1987) Characterisation of human LH isoforms from fresh pituitary tissue. Mol. Cell. Endocrinol., 54, 115-121.
37. Stoning, P.L. and Gaines Das, R.E. (1993) The second international standard for human pituitary LH: its collaborative study by bioassay and immunoassays. J. Endocrinol., 138, 345-359.
38. Stoning, P.L. (1992) Assaying glycoprotein hormones - the influence of glycosylation on immunoreactivity. Trends Biotechnol., 10, 427-431.
39. Strollo, F., Harlin, J., Hernandez-Montes, H. et al. (1981) Qualitative and quantitative differences in the isoelectrofocusing profile of biologically active lutropin in the blood of normally menstruating and post-menopausal women. Acta Endocrinol., 97, 166-175.
40. Ulloa-Aguirre, A., Espinoza, R., Damian-Matsumura, R.E. and Chappel, S.C. (1988) Immunological and biological potencies of the different molecular species of gonadotrophins. Hum. Reprod., 3, 491-501.
41. Van Damme, M., Robertson, D.M. and Diczfalusy, E. (1974) An improved in-vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol., 77, 665-671.
42. Van Hell, H., Maathijsen, R. and Overbeek, G. (1964) Effects of human menopausal gonadotropin preparations in different bioassay methods. Acta Endocrinol., 47, 409-118.
43. Weston, A.M., Zelinskiwooten, M.B., Hutchison, J.S. et al. (1996) Developmental potential of embryos produced by in-vitro fertilization from gonadotropin-releasing-hormone antagonist-treated macaques stimulated with recombinant human follicle-stimulating-hormone alone or in combination with luteinizing-hormone. Hum. Reprod., 11, 608-613.
44. Wide, L., Albertsson-Wikland, K. and Phillips, D.J. (1996) More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children. J. Clin. Endocrinol. Metab., 81, 216-221.
45. Wide, L. and Naessen, T. (1994) 17β-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause. Clin. Endocrinol., 40, 783-789.
46. Wide, L. and Bakos, O. (1993) More basic forms of human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase. J. Clin. Endocrinol. Metab., 76, 885-889.
47. Wide, L. (1985) Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. II. Relationship to sex and age. Acta Endocrinol., 109, 190-197.
48. Zambrano, E., Olivares, A., Pablo Mendez, J. et al. (1995) Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle. J. Clin. Endocrinol. Metab., 80, 1647-1656.
49. Zelinski-Wooten, M.B., Hutchison, J.S., Hess, D.L. et al. (1995) Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum. Reprod., 10, 1658-1666.